The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Trastuzumab-based adjuvant chemotherapy for breast cancer: Early myocardial dysfunction detected by “speckle tracking” echocardiography (STE).
Giovanni Mantovani
No relevant relationships to disclose
Mariele Dessi
No relevant relationships to disclose
Laura Orgiano
No relevant relationships to disclose
Alessandra Piras
No relevant relationships to disclose
Christian Cadeddu
No relevant relationships to disclose
Martino Deidda
No relevant relationships to disclose
Massimo Ghiani
No relevant relationships to disclose
Giorgia Antoni
No relevant relationships to disclose
Roberto Serpe
No relevant relationships to disclose
Giuseppe Mercuro
No relevant relationships to disclose